Even as boom wanes, a new $200M SPAC is still hop­ing for an­oth­er big score

4 years ago
Financing

Bio­haven shakes up lead­er­ship team as it feels the heat from mi­graine com­peti­tors

4 years ago
People

No­var­tis pe­ti­tions FDA to block 18 gener­ic com­peti­tors for its megablock­buster heart drug un­til 2024

4 years ago
Pharma
FDA+

The 2022 wave com­ing? Top an­a­lyst says Big Phar­ma will have more than $1T avail­able to sat­is­fy its grow­ing ap­petite ...

4 years ago
Deals
Bioregnum

Covid-19 roundup: Val­ne­va de­fends vac­cine in wake of un­flat­ter­ing boost­er study; Mer­ck goes af­ter Pfiz­er’s new ...

4 years ago
Coronavirus

Gilead re­calls 2 lots of Vek­lury af­ter in­ves­ti­ga­tion con­firms com­plaint of glass par­tic­u­lates

4 years ago
Coronavirus

Keytru­da wins eighth FDA ap­proval of 2021, mov­ing in­to ad­ju­vant and pe­di­atric melanoma set­tings

4 years ago
FDA+

Adicet un­veils ear­ly re­spons­es for off-the-shelf drug lever­ag­ing rare T cells. Will dura­bil­i­ty hold up?

4 years ago
R&D
Cell/Gene Tx

Ae­glea's en­gi­neered en­zyme flops out­comes test in rare meta­bol­ic dis­ease. Is re­duc­ing a key bio­mark­er enough for an ...

4 years ago
R&D

All about Omi­cron; We need more Covid an­tivi­rals; GSK snags Pfiz­er’s vac­cine ex­ec; Janet Wood­cock’s fu­ture at ...

4 years ago
Weekly

FDA tacks on new warn­ing to Ab­b­Vie's Rin­voq la­bel as safe­ty frets crimp JAK class

4 years ago
Marketing

Thank­ful for nurs­es: J&J's new cam­paign aims to re­set pan­dem­ic clock back to grat­i­tude

4 years ago
Pharma
Marketing

Biospec­i­men M&A: Dis­cov­ery ac­quires Al­bert Li's he­pa­to­cyte project; PhI­II tri­al on Bay­er's Nube­qa reached pri­ma­ry ...

4 years ago
News Briefing
Cell/Gene Tx

Pfiz­er, Am­gen and Janssen seek fur­ther clar­i­ty on FDA's new ben­e­fit-risk guid­ance

4 years ago
R&D
FDA+

Drug­mak­ers cut prices on av­er­age by more than 60% to get on Chi­na's 2022 NDRL list — re­port

4 years ago
China
Pharma

Re­searchers move clos­er to de­ci­pher­ing blood clots from As­traZeneca, J&J's Covid-19 vac­cines

4 years ago
Discovery
Coronavirus

Stoke touts ear­ly signs of ef­fi­ca­cy for Dravet syn­drome drug

4 years ago
R&D

Covid-19 roundup: Ugur Sahin says new shots like­ly need­ed for Omi­cron; UK ful­ly ap­proves Vir/Glax­o­SmithK­line an­ti­body

4 years ago
Coronavirus

Janet Wood­cock plots her fu­ture at FDA, with se­nior ad­vi­sor role to fall back on if Califf wins con­fir­ma­tion

4 years ago
FDA+

Ac­cel­er­at­ed ap­proval re­forms need mean­ing­ful con­fir­ma­to­ry tri­al im­prove­ments, pro­fes­sors write in Sci­ence

4 years ago
FDA+

As­traZeneca nix­es $8B So­bi buy­out over fears a for­mer drug would be sold to ri­vals — re­port

4 years ago
Deals

Joseph Ar­ron march­es to the beat of his own drum at 23andMe; Ex-Voy­ager CFO joins Sek Kathire­san at Verve ...

4 years ago
Peer Review

Com­mon, Jamie Foxx among celebs stand­ing up for clin­i­cal tri­als in star-stud­ded can­cer group's pan­dem­ic push

4 years ago
Pharma
Marketing

Ex-Im­munomedics CFO charged with in­sid­er trad­ing, faces up to 20 years in prison af­ter al­leged­ly tip­ping off ...

4 years ago
Pharma
First page Previous page 614615616617618619620 Next page Last page
A service from the Financial Times